Search
Fortress Biotech Inc
FBIOAdd to Watchlist
2.990USD
-0.080-2.61%
Close 06/18, 16:00（ET）Quotes delayed by 15 min
99.33MMarket Cap
0.78P/E TTM
Earnings Forecast
Currency: USD Updated: 2026-06-18The current earnings forecast score of Fortress Biotech Inc is 8.00, ranking 55 out of 157 in the Pharmaceuticals industry. The average price target is 10.75, with a high of 17.00 and a low of 4.50.
Analyst Rating
Based on
2
analysts
Buy
Current Rating
11.000
Target Price
+267.89%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
175
Total
6
Median
8
Average
Company name
Ratings
Analysts
Fortress Biotech Inc
FBIO
2
Amgen Inc
AMGN
38
Biogen Inc
BIIB
38
Eli Lilly and Co
LLY
35
AbbVie Inc
ABBV
34
Vertex Pharmaceuticals Inc
VRTX
34
1
2
3
...
35
Support & Resistance
Relevant data have not been disclosed by the company yet.
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
FAQs
What is Fortress Biotech Inc's expected revenue for the next quarter?
Fortress Biotech Inc's expected revenue is 18.30M.
What is Fortress Biotech Inc's price target?
Analysts forecast that Fortress Biotech Inc's price target is USD 10.75, with the highest forecast at USD 17.00 and the lowest forecast at USD 4.50.
How have Fortress Biotech IncFBIO's recent earnings per share performed?
The market expectation was USD 3.44, while Fortress Biotech IncFBIO's earnings per share (EPS) for the previous quarter was USD -0.20. EPS for the next quarter is expected at USD -0.20.
What is the analyst rating for Fortress Biotech Inc?
Based on the ratings of Fortress Biotech Inc's stock from 2 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.
